HDAC9 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "HDAC9" in English language version.

refsWebsite

Global rank English rank

28nih.gov

4^th place

17doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1harvard.edu

18^th place

17^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, et al. (November 1999). "HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor". Molecular and Cellular Biology. 19 (11): 7816–7827. doi:10.1128/mcb.19.11.7816. PMC 84849. PMID 10523670.
Sparrow DB, Miska EA, Langley E, Reynaud-Deonauth S, Kotecha S, Towers N, et al. (September 1999). "MEF-2 function is modified by a novel co-repressor, MITR". The EMBO Journal. 18 (18): 5085–5098. doi:10.1093/emboj/18.18.5085. PMC 1171579. PMID 10487760.
Cai Y, Huang D, Ma W, Wang M, Qin Q, Jiang Z, Liu M (August 2021). "Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11". Journal of Drug Targeting. 29 (7): 761–770. doi:10.1080/1061186X.2021.1878365. PMID 33480300. S2CID 231678641.
Li B, Hu C, Liu J, Liao X, Xun J, Xiao M, Yan J (July 2019). "Associations among Genetic Variants and Intracranial Aneurysm in a Chinese Population". Yonsei Medical Journal. 60 (7): 651–658. doi:10.3349/ymj.2019.60.7.651. PMC 6597466. PMID 31250579.
Shen J, Han Q, Li W, Chen X, Lu J, Zheng J, Xue S (August 2022). "miR-383-5p Regulated by the Transcription Factor CTCF Affects Neuronal Impairment in Cerebral Ischemia by Mediating Deacetylase HDAC9 Activity". Molecular Neurobiology. 59 (10): 6307–6320. doi:10.1007/s12035-022-02840-4. PMID 35927544. S2CID 251349105.
Zhong L, Yan J, Li H, Meng L (2020). "HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury via miR-20a-Dependent Downregulation of NeuroD1". Frontiers in Cellular Neuroscience. 14 544285. doi:10.3389/fncel.2020.544285. PMC 7873949. PMID 33584204.
Yang R, Wu Y, Wang M, Sun Z, Zou J, Zhang Y, Cui H (April 2015). "HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation". Oncotarget. 6 (10): 7644–7656. doi:10.18632/oncotarget.3223. PMC 4480706. PMID 25760078.
Shimbo H, Oyoshi T, Kurosawa K (January 2018). "Contiguous gene deletion neighboring TWIST1 identified in a patient with Saethre-Chotzen syndrome associated with neurodevelopmental delay: Possible contribution of HDAC9". Congenital Anomalies. 58 (1): 33–35. doi:10.1111/cga.12216. PMID 28220539. S2CID 44464369.
Méjat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, Schaeffer L (March 2005). "Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression". Nature Neuroscience. 8 (3): 313–321. doi:10.1038/nn1408. PMID 15711539. S2CID 9965030.
Asare Y, Campbell-James TA, Bokov Y, Yu LL, Prestel M, El Bounkari O, et al. (August 2020). "Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability". Circulation Research. 127 (6): 811–823. doi:10.1161/CIRCRESAHA.120.316743. PMID 32546048. S2CID 219726725.
Zhang CL, McKinsey TA, Olson EN (October 2002). "Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation". Molecular and Cellular Biology. 22 (20): 7302–7312. doi:10.1128/mcb.22.20.7302-7312.2002. PMC 139799. PMID 12242305.
Petrie K, Guidez F, Howell L, Healy L, Waxman S, Greaves M, Zelent A (May 2003). "The histone deacetylase 9 gene encodes multiple protein isoforms". The Journal of Biological Chemistry. 278 (18): 16059–16072. doi:10.1074/jbc.M212935200. PMID 12590135.
Zhou X, Richon VM, Rifkind RA, Marks PA (February 2000). "Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5". Proceedings of the National Academy of Sciences of the United States of America. 97 (3): 1056–1061. Bibcode:2000PNAS...97.1056Z. doi:10.1073/pnas.97.3.1056. PMC 15519. PMID 10655483.
Micheli L, D'Andrea G, Leonardi L, Tirone F (July 2017). "HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression". Journal of Cellular Physiology. 232 (7): 1696–1707. doi:10.1002/jcp.25467. PMID 27333946. S2CID 4070837.
Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (September 1999). "HDAC4 deacetylase associates with and represses the MEF2 transcription factor". The EMBO Journal. 18 (18): 5099–5107. doi:10.1093/emboj/18.18.5099. PMC 1171580. PMID 10487761.
Lemercier C, Verdel A, Galloo B, Curtet S, Brocard MP, Khochbin S (May 2000). "mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity". The Journal of Biological Chemistry. 275 (20): 15594–15599. doi:10.1074/jbc.M908437199. PMID 10748098. S2CID 39220205.
Koipally J, Georgopoulos K (June 2002). "Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression". The Journal of Biological Chemistry. 277 (26): 23143–23149. doi:10.1074/jbc.M202079200. PMID 11959865.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000048052 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000004698 – Ensembl, May 2017

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Zhou X, Richon VM, Rifkind RA, Marks PA (February 2000). "Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5". Proceedings of the National Academy of Sciences of the United States of America. 97 (3): 1056–1061. Bibcode:2000PNAS...97.1056Z. doi:10.1073/pnas.97.3.1056. PMC 15519. PMID 10655483.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, et al. (November 1999). "HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor". Molecular and Cellular Biology. 19 (11): 7816–7827. doi:10.1128/mcb.19.11.7816. PMC 84849. PMID 10523670.
Sparrow DB, Miska EA, Langley E, Reynaud-Deonauth S, Kotecha S, Towers N, et al. (September 1999). "MEF-2 function is modified by a novel co-repressor, MITR". The EMBO Journal. 18 (18): 5085–5098. doi:10.1093/emboj/18.18.5085. PMC 1171579. PMID 10487760.
Cai Y, Huang D, Ma W, Wang M, Qin Q, Jiang Z, Liu M (August 2021). "Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11". Journal of Drug Targeting. 29 (7): 761–770. doi:10.1080/1061186X.2021.1878365. PMID 33480300. S2CID 231678641.
Li B, Hu C, Liu J, Liao X, Xun J, Xiao M, Yan J (July 2019). "Associations among Genetic Variants and Intracranial Aneurysm in a Chinese Population". Yonsei Medical Journal. 60 (7): 651–658. doi:10.3349/ymj.2019.60.7.651. PMC 6597466. PMID 31250579.
Shen J, Han Q, Li W, Chen X, Lu J, Zheng J, Xue S (August 2022). "miR-383-5p Regulated by the Transcription Factor CTCF Affects Neuronal Impairment in Cerebral Ischemia by Mediating Deacetylase HDAC9 Activity". Molecular Neurobiology. 59 (10): 6307–6320. doi:10.1007/s12035-022-02840-4. PMID 35927544. S2CID 251349105.
Zhong L, Yan J, Li H, Meng L (2020). "HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury via miR-20a-Dependent Downregulation of NeuroD1". Frontiers in Cellular Neuroscience. 14 544285. doi:10.3389/fncel.2020.544285. PMC 7873949. PMID 33584204.
Yang R, Wu Y, Wang M, Sun Z, Zou J, Zhang Y, Cui H (April 2015). "HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation". Oncotarget. 6 (10): 7644–7656. doi:10.18632/oncotarget.3223. PMC 4480706. PMID 25760078.
Shimbo H, Oyoshi T, Kurosawa K (January 2018). "Contiguous gene deletion neighboring TWIST1 identified in a patient with Saethre-Chotzen syndrome associated with neurodevelopmental delay: Possible contribution of HDAC9". Congenital Anomalies. 58 (1): 33–35. doi:10.1111/cga.12216. PMID 28220539. S2CID 44464369.
Méjat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, Schaeffer L (March 2005). "Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression". Nature Neuroscience. 8 (3): 313–321. doi:10.1038/nn1408. PMID 15711539. S2CID 9965030.
Asare Y, Campbell-James TA, Bokov Y, Yu LL, Prestel M, El Bounkari O, et al. (August 2020). "Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability". Circulation Research. 127 (6): 811–823. doi:10.1161/CIRCRESAHA.120.316743. PMID 32546048. S2CID 219726725.
Zhang CL, McKinsey TA, Olson EN (October 2002). "Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation". Molecular and Cellular Biology. 22 (20): 7302–7312. doi:10.1128/mcb.22.20.7302-7312.2002. PMC 139799. PMID 12242305.
Petrie K, Guidez F, Howell L, Healy L, Waxman S, Greaves M, Zelent A (May 2003). "The histone deacetylase 9 gene encodes multiple protein isoforms". The Journal of Biological Chemistry. 278 (18): 16059–16072. doi:10.1074/jbc.M212935200. PMID 12590135.
Zhou X, Richon VM, Rifkind RA, Marks PA (February 2000). "Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5". Proceedings of the National Academy of Sciences of the United States of America. 97 (3): 1056–1061. Bibcode:2000PNAS...97.1056Z. doi:10.1073/pnas.97.3.1056. PMC 15519. PMID 10655483.
Micheli L, D'Andrea G, Leonardi L, Tirone F (July 2017). "HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression". Journal of Cellular Physiology. 232 (7): 1696–1707. doi:10.1002/jcp.25467. PMID 27333946. S2CID 4070837.
Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (September 1999). "HDAC4 deacetylase associates with and represses the MEF2 transcription factor". The EMBO Journal. 18 (18): 5099–5107. doi:10.1093/emboj/18.18.5099. PMC 1171580. PMID 10487761.
Lemercier C, Verdel A, Galloo B, Curtet S, Brocard MP, Khochbin S (May 2000). "mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity". The Journal of Biological Chemistry. 275 (20): 15594–15599. doi:10.1074/jbc.M908437199. PMID 10748098. S2CID 39220205.
Koipally J, Georgopoulos K (June 2002). "Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression". The Journal of Biological Chemistry. 277 (26): 23143–23149. doi:10.1074/jbc.M202079200. PMID 11959865.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, et al. (November 1999). "HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor". Molecular and Cellular Biology. 19 (11): 7816–7827. doi:10.1128/mcb.19.11.7816. PMC 84849. PMID 10523670.
Sparrow DB, Miska EA, Langley E, Reynaud-Deonauth S, Kotecha S, Towers N, et al. (September 1999). "MEF-2 function is modified by a novel co-repressor, MITR". The EMBO Journal. 18 (18): 5085–5098. doi:10.1093/emboj/18.18.5085. PMC 1171579. PMID 10487760.
"Entrez Gene: HDAC9 histone deacetylase 9".
Li B, Hu C, Liu J, Liao X, Xun J, Xiao M, Yan J (July 2019). "Associations among Genetic Variants and Intracranial Aneurysm in a Chinese Population". Yonsei Medical Journal. 60 (7): 651–658. doi:10.3349/ymj.2019.60.7.651. PMC 6597466. PMID 31250579.
Zhong L, Yan J, Li H, Meng L (2020). "HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury via miR-20a-Dependent Downregulation of NeuroD1". Frontiers in Cellular Neuroscience. 14 544285. doi:10.3389/fncel.2020.544285. PMC 7873949. PMID 33584204.
Yang R, Wu Y, Wang M, Sun Z, Zou J, Zhang Y, Cui H (April 2015). "HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation". Oncotarget. 6 (10): 7644–7656. doi:10.18632/oncotarget.3223. PMC 4480706. PMID 25760078.
Zhang CL, McKinsey TA, Olson EN (October 2002). "Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation". Molecular and Cellular Biology. 22 (20): 7302–7312. doi:10.1128/mcb.22.20.7302-7312.2002. PMC 139799. PMID 12242305.
Zhou X, Richon VM, Rifkind RA, Marks PA (February 2000). "Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5". Proceedings of the National Academy of Sciences of the United States of America. 97 (3): 1056–1061. Bibcode:2000PNAS...97.1056Z. doi:10.1073/pnas.97.3.1056. PMC 15519. PMID 10655483.
Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (September 1999). "HDAC4 deacetylase associates with and represses the MEF2 transcription factor". The EMBO Journal. 18 (18): 5099–5107. doi:10.1093/emboj/18.18.5099. PMC 1171580. PMID 10487761.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Cai Y, Huang D, Ma W, Wang M, Qin Q, Jiang Z, Liu M (August 2021). "Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11". Journal of Drug Targeting. 29 (7): 761–770. doi:10.1080/1061186X.2021.1878365. PMID 33480300. S2CID 231678641.
Shen J, Han Q, Li W, Chen X, Lu J, Zheng J, Xue S (August 2022). "miR-383-5p Regulated by the Transcription Factor CTCF Affects Neuronal Impairment in Cerebral Ischemia by Mediating Deacetylase HDAC9 Activity". Molecular Neurobiology. 59 (10): 6307–6320. doi:10.1007/s12035-022-02840-4. PMID 35927544. S2CID 251349105.
Shimbo H, Oyoshi T, Kurosawa K (January 2018). "Contiguous gene deletion neighboring TWIST1 identified in a patient with Saethre-Chotzen syndrome associated with neurodevelopmental delay: Possible contribution of HDAC9". Congenital Anomalies. 58 (1): 33–35. doi:10.1111/cga.12216. PMID 28220539. S2CID 44464369.
Méjat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, Schaeffer L (March 2005). "Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression". Nature Neuroscience. 8 (3): 313–321. doi:10.1038/nn1408. PMID 15711539. S2CID 9965030.
Asare Y, Campbell-James TA, Bokov Y, Yu LL, Prestel M, El Bounkari O, et al. (August 2020). "Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability". Circulation Research. 127 (6): 811–823. doi:10.1161/CIRCRESAHA.120.316743. PMID 32546048. S2CID 219726725.
Micheli L, D'Andrea G, Leonardi L, Tirone F (July 2017). "HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression". Journal of Cellular Physiology. 232 (7): 1696–1707. doi:10.1002/jcp.25467. PMID 27333946. S2CID 4070837.
Lemercier C, Verdel A, Galloo B, Curtet S, Brocard MP, Khochbin S (May 2000). "mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity". The Journal of Biological Chemistry. 275 (20): 15594–15599. doi:10.1074/jbc.M908437199. PMID 10748098. S2CID 39220205.

HDAC9 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)